Hydrochloric Acid

Hydrochloric Acid

SCHEMBL1450190

CC1=C(C)C(C)(C)C([Ru+2])=C1C.[Cl-].[Cl-]

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CTSD P07339 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14954366 0.94 CTSD (0.33) CTSD
Bromide SCHEMBL14953769 0.94 CTSD (0.33) CTSD
Fluoride Ion SCHEMBL14954491 0.94 CTSD (0.33) CTSD
Iodide SCHEMBL14954346 0.94 CTSD (0.33) CTSD
SCHEMBL2230540 0.73 CTSD (0.43) CTSD
SCHEMBL8652405 0.67 CTSD (0.31) CTSD
Hydrochloric Acid SCHEMBL7869576 0.67 CTSD (0.35) CTSD
SCHEMBL28961651 0.65 CTSD (0.38) CTSD
Hydrochloric Acid SCHEMBL6813955 0.65 CTSD (0.33) CTSD
Hydrochloric Acid SCHEMBL7808272 0.65 CTSD (0.33) CTSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023280073-A1 METHOD FOR PREPARING NITROGEN-CONTAINING POLYCYCLIC FUSED RING COMPOUND, AND INTERMEDIATE AND USE OF COMPOUND 北京志健金瑞生物医药科技有限公司 2023-01-12 WO claimed
WO-2023280073-A1 METHOD FOR PREPARING NITROGEN-CONTAINING POLYCYCLIC FUSED RING COMPOUND, AND INTERMEDIATE AND USE OF COMPOUND 北京志健金瑞生物医药科技有限公司 2023-01-12 WO disclosed
US-8722912-B2 Metal complex compound and process for producing amides utilizing the metal complex compound NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY (JP) 2014-05-13 US disclosed
US-20130131366-A1 Metal Complex Compound and Process for Producing Amides Utilizing the Metal Complex Compound NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY (JP) 2013-05-23 US disclosed
US-7910272-B2 Dye-containing photosensitive composition, color filter using the same, and production method thereof FUJIFILM CORPORATION (JP) 2011-03-22 US disclosed
US-20070190435-A1 Dye-containing photosensitive composition, color filter using the same, and production method thereof FUJIFILM CORPORATION (JP) 2007-08-16 US disclosed
US-20070184366-A1 DYE CONTAINING CURABLE COMPOSITION, COLOR FILTER, AND PROCESS OF PREPARING COLOR FILTER FUJIFILM CORPORATION 2007-08-09 US disclosed
US-20070099096-A1 Dye-containing curable composition, color filter and method of producing thereof FUJIFILM CORPORATION 2007-05-03 US disclosed
US-20040185372-A1 Dye-containing curable composition, color filter, and process of preparing color filter FUJI PHOTO FILM CO., LTD. 2004-09-23 US disclosed
US-5352488-A Chemical vapor deposition process employing metal pentadienyl complexes SYRACUSE UNIVERSITY 1994-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130131366-A1 Metal Complex Compound and Process for Producing Amides Utilizing the Metal Complex Compound AP2M1, ASH2L, AP2A1 CTSD 4711/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.